Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Neurocrine

3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

MarketBeat

Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug

Neurocrine Biosciences shares catapulted Tuesday on "surprising commercial momentum" for its newest drug, Crenessity.

Investors Business Daily

Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Neurocrine Jumps After Snagging FDA Approval For A First-In-Decades Drug

Neurocrine Biosciences stock jumped Monday after the company won FDA approval for the first new treatment for an adrenal disease in decade

Investors Business Daily

3 Top Growth Stocks to Buy at a Discount This Month

According to analysts, here are three top-notch mid-cap growth stocks to snag at a discount now.

Barchart

Neurocrine Plummets 19% — Does It Still Have A Shot At This 'Significant Market Opportunity?'

Neurocrine Biosciences stock plummeted Wednesday after the company announced midstage test results for a schizophrenia treatment that lags its peers.

Investors Business Daily

Nvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam

Nvidia stock along with four other leading stocks are in or near buy areas as the market rally appears to be picking up steam.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Why Things Are Looking Up For IBD Stock Of The Day Neurocrine, A Top 1% Biotech

Neurocrine stock rose Wednesday after the leading biotech topped Wall Street's sales expectations and wrapped a key regulatory filing.

Investors Business Daily

Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?

Top-notch biotech stock Neurocrine surged Tuesday after analysts suggested the company's depression treatment could rival ketamine.

Investors Business Daily

Nvidia Fails To Hold 900 As Uber Leads These Stocks To Watch

As shares of Meta and Nvidia stock hold near highs, Uber, CyberArk and four other growth stocks set up bases and buy zones.

Investors Business Daily

The $1 Billion Opportunity Driving IBD Stock Of The Day Neurocrine Higher

Neurocrine s Monday's IBD Stock Of The Day. Milestones are stacking up in 2024 and Neurocrine stock just topped its 50-day line.

Investors Business Daily

The $660 Million Opportunity That's Driving IBD Stock Of The Day Neurocrine Biosciences Higher

Neurocrine is Tuesday's IBD Stock Of The Day. After it unveiled promising results for a genetic disease drug, NBIX stock is on the rise.

Investors Business Daily

Can Neurocrine Erase Its Recent Setbacks With This Jump To An Eight-Month High?

Neurocrine said Tuesday its experimental drug could help lower steroid use for patients with a rare, adrenal disease. NBIX stock surged.

Investors Business Daily

Neurocrine Reports 3,000% Profit Growth, But Shares Unexpectedly Tumble

Neurocrine reported soaring fourth-quarter profit Monday and issued in-line guidance for Ingrezza. But NBIX stock toppled.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rallies 300 Points After Jobless Claims; Tesla Stock Surges On Reiterated Buy Rating

The Dow Jones rallied Thursday after first-time jobless claims. Tesla stock raced higher on a reiterated overweight rating.

Investors Business Daily

Dow Jones Rises After Weak Housing Data; Tesla Stock Hits New Low Amid Historic Plunge

The Dow Jones rose Wednesday after key economic data. Tesla stock hit a new low, threatening to add to December's historic plunge.

Investors Business Daily

Dow Jones Falls After Housing Data As Apple Hits New Low; Tesla Plunges On Reduced Production Schedule In China

The Dow Jones Industrial Average turned lower after economic data. Tesla dived on a report that the EV giant will run a reduced production schedule at its Shanghai plant in January.

Investors Business Daily

Dow Jones Falls On Inflation Data; Tesla Stock Hits New Low Amid Elon Musk Comments

The Dow Jones Industrial Average dropped Friday on key inflation data. Tesla stock hit a new low amid Elon Musk's comments on not selling shares.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Dives After GDP, Jobless Data; CarMax Plunges On 'Vehicle Affordability Issues'

The Dow Jones dived more than 400 points Thursday after first-time jobless claims and GDP. CarMax plunged on "vehicle affordability issues."

Investors Business Daily

Dow Jones Rallies After Economic Data; Nike Surges 15% On Earnings; Tesla Hits New Low

The Dow Jones rallied 375 points Wednesday after consumer and housing data, as Nike stock surged 15% on strong earnings results.

Investors Business Daily

Dow Jones Reverses Higher; Tesla Stock Hits New Low On Price Target Cuts

The Dow Jones Industrial Average reversed higher Tuesday. Tesla stock hit a new low on multiple price-target cuts.

Investors Business Daily

Dow Jones Extends Losing Streak As Apple Sells Off; Tesla Hits New Low Amid Elon Musk Twitter Poll

Dow Jones futures were higher early Tuesday. Apple shares sold off again and are approaching new lows, while Tesla stock hit a new low.

Investors Business Daily

Dow Jones Falls As Stock Market Continues To Drop; Tesla Down After Elon Musk Twitter Poll

The Dow Jones Industrial Average fell Monday after last week's heavy losses. Tesla stock jumped early on Elon Musk's Twitter poll that said he should step down, but quickly reversed lower.

Investors Business Daily

Blazing Hot Neurocrine Biosciences, With 40% Run This Year, Extends Breakout On Quarterly Beat

Neurocrine Biosciences beat third-quarter forecasts and raised its Ingrezza outlook for 2022, leading NBIX stock to jump Tuesday.

Investors Business Daily

Dow Jones Reverses Ahead Of Earnings Season; Tesla Hits Record China Deliveries

The Dow Jones Industrial Average reversed lower Monday ahead of earnings season. Tesla stock reported record China deliveries in September.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations